A Virtual Reality Brief Violence Intervention: Preventing Gun Violence Among Violently Injured Adults
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Jan 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help reduce gun violence among adults who have been victims of violent crime. The researchers are testing a program called Brief Violence Intervention-Virtual Reality (BVI-VR), which uses virtual reality technology to help people cope with their experiences and make safer choices. The goal is to see if this program can lower the chances of being hurt again, as well as improve the overall well-being of participants. They will gather information from various sources, including hospital records and self-reports, to understand the program's effectiveness.
To be eligible for this trial, participants must be at least 18 years old, speak English, and have been violently injured, specifically at VCU's Level 1 Trauma Center. The study is currently recruiting participants, and anyone who joins can expect to take part in assessments and surveys that will help the researchers understand how the program impacts their lives. This is an important opportunity to contribute to finding new ways to prevent further violence and improve the health of those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • violently injured patients from VCU's Level 1 Trauma Center
- • 18 years or older
- • English-speaking
- Exclusion Criteria:
- • Under 18 years old
- • Not a victim of Violent crime
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
Nicholas Thomson
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported